Investor alert: law offices of howard g. smith announces investigation of nrx pharmaceuticals, inc. (nrxp) on behalf of investors

Bensalem, pa.--(business wire)--law offices of howard g. smith announces an investigation on behalf of nrx pharmaceuticals, inc. (“nrx” or the “company”) (nasdaq: nrxp) investors concerning the company's possible violations of the federal securities laws. in june 2021, nrx announced that it filed an application with u.s. food and drug administration (“fda”) requesting emergency use authorization (“eua”) for zyesami (aviptadil-acetate) to treat critically ill covid-19 patients suffering with res
NRXP Ratings Summary
NRXP Quant Ranking